← Back to Search

Narrative Exposure Therapy for PTSD in Homeless Women

Phase 1
Recruiting
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will study how to improve the health of homeless women with PTSD+SUD who often suffer with severe illness and early death.

Who is the study for?
This trial is for women over 18 who are currently or recently homeless, have problematic substance use, and suffer from trauma-related distress. They must have experienced a traumatic event and show signs of PTSD. Women can't join if they don't meet these specific conditions.
What is being tested?
The study tests Narrative Exposure Therapy (NET+) immediately versus after a waiting period for women with PTSD and substance use disorders. It aims to see how effective NET+ is in reducing the health consequences of untreated trauma among homeless women.
What are the potential side effects?
While the description doesn’t specify side effects, psychological therapies like NET+ may sometimes cause temporary increases in distress as individuals confront traumatic memories during treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Post-Traumatic Stress Disorder Symptoms
Secondary study objectives
Anxiety
Depression
Sleep Problems
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Immediate NET+Experimental Treatment1 Intervention
Receives NET+ immediately
Group II: Waitlist NET+Active Control1 Intervention
Receives NET+ after waitlist

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Rush University Medical CenterLead Sponsor
436 Previous Clinical Trials
249,314 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
369 Previous Clinical Trials
412,814 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,816 Previous Clinical Trials
8,161,689 Total Patients Enrolled

Media Library

Immediate Narrative Exposure Therapy (NET)+ Clinical Trial Eligibility Overview. Trial Name: NCT05873517 — Phase 1
Psychological Trauma Research Study Groups: Immediate NET+, Waitlist NET+
Psychological Trauma Clinical Trial 2023: Immediate Narrative Exposure Therapy (NET)+ Highlights & Side Effects. Trial Name: NCT05873517 — Phase 1
Immediate Narrative Exposure Therapy (NET)+ 2023 Treatment Timeline for Medical Study. Trial Name: NCT05873517 — Phase 1
~2 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top